Use of Synvisc® in Knee Osteoarthritis - Survey on Practice

Use of SYNVISC in Knee Osteoarthritis. Survey on Practice. U.S.A.G.E Pratique

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT02195544

Enrollment

Registered

2014-07-21

Start date

1998-10-31

Completion date

Unknown

Last updated

2014-07-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Osteoarthritis

Brief summary

Study of prescription methods in everyday medical practice, tolerance profile and effect of Synvisc® until six months of follow-up.

Interventions

DRUGSynvisc®

Study design

Observational model

COHORT

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Healthy volunteers

Inclusion criteria

* not applicable

Exclusion criteria

* none

Design outcomes

Primary

Measure	Time frame	Description
Change in clinical symptoms	up to 6 months	assessed via questionnaire
Amount of medication consumed	up to 6 months	—
Patient satisfaction on a 4-point verbal rating scale	up to 6 months	—

Secondary

Measure	Time frame
Number of patients with adverse events	up to 6 months

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026